CO4910140A1 - Intermediarios y proceso para preparar olanzapina - Google Patents

Intermediarios y proceso para preparar olanzapina

Info

Publication number
CO4910140A1
CO4910140A1 CO97055061A CO97055061A CO4910140A1 CO 4910140 A1 CO4910140 A1 CO 4910140A1 CO 97055061 A CO97055061 A CO 97055061A CO 97055061 A CO97055061 A CO 97055061A CO 4910140 A1 CO4910140 A1 CO 4910140A1
Authority
CO
Colombia
Prior art keywords
intermediaries
olanzapine
prepare olanzapine
prepare
drying
Prior art date
Application number
CO97055061A
Other languages
English (en)
Spanish (es)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4910140(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO4910140A1 publication Critical patent/CO4910140A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO97055061A 1996-09-23 1997-09-22 Intermediarios y proceso para preparar olanzapina CO4910140A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
CO4910140A1 true CO4910140A1 (es) 2000-04-24

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97055061A CO4910140A1 (es) 1996-09-23 1997-09-22 Intermediarios y proceso para preparar olanzapina

Country Status (35)

Country Link
US (1) US6020487A (OSRAM)
EP (1) EP0831098B1 (OSRAM)
JP (2) JP2001500877A (OSRAM)
KR (1) KR100560015B1 (OSRAM)
CN (1) CN1122036C (OSRAM)
AR (1) AR013838A1 (OSRAM)
AT (1) ATE209208T1 (OSRAM)
AU (1) AU719441B2 (OSRAM)
BR (1) BR9712100A (OSRAM)
CA (1) CA2265712C (OSRAM)
CO (1) CO4910140A1 (OSRAM)
CZ (1) CZ299248B6 (OSRAM)
DE (1) DE69708428T2 (OSRAM)
DK (1) DK0831098T3 (OSRAM)
EA (1) EA001642B1 (OSRAM)
EG (1) EG23861A (OSRAM)
ES (1) ES2166051T3 (OSRAM)
HU (1) HU226484B1 (OSRAM)
ID (1) ID27275A (OSRAM)
IL (1) IL128962A (OSRAM)
IN (1) IN187156B (OSRAM)
MY (1) MY125565A (OSRAM)
NO (1) NO323980B1 (OSRAM)
NZ (1) NZ334448A (OSRAM)
PE (1) PE110398A1 (OSRAM)
PL (3) PL196069B1 (OSRAM)
PT (1) PT831098E (OSRAM)
RS (1) RS49598B (OSRAM)
SI (1) SI0831098T1 (OSRAM)
SV (1) SV1997000081A (OSRAM)
TR (1) TR199900640T2 (OSRAM)
TW (1) TW470746B (OSRAM)
UA (1) UA59371C2 (OSRAM)
WO (1) WO1998012199A1 (OSRAM)
ZA (1) ZA978515B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
AU2002367119A1 (en) 2001-12-24 2003-07-15 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
PT1611139E (pt) * 2003-12-22 2008-07-17 Teva Pharma Métodos de preparação de olanzapina
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
EP2623095A1 (en) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EP0582368B1 (en) * 1992-05-29 2001-01-24 Eli Lilly And Company Limited Thienobenzodiazepine derivatives for treatment of CNS disorders
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
RS49597B (sr) * 1996-09-23 2007-06-04 Eli Lilly And Company, Olanzapin dihidrat d

Also Published As

Publication number Publication date
SV1997000081A (es) 1999-01-14
JP2009242407A (ja) 2009-10-22
ATE209208T1 (de) 2001-12-15
RS49598B (sr) 2007-06-04
NO323980B1 (no) 2007-07-30
PL194565B1 (pl) 2007-06-29
PL332482A1 (en) 1999-09-13
ZA978515B (en) 1999-03-23
IL128962A (en) 2003-01-12
KR100560015B1 (ko) 2006-03-15
EP0831098A2 (en) 1998-03-25
IL128962A0 (en) 2000-02-17
PE110398A1 (es) 1999-01-14
YU15599A (sh) 2001-12-26
CZ99099A3 (cs) 1999-11-17
CA2265712C (en) 2006-10-31
PL196069B1 (pl) 2007-12-31
AU4484197A (en) 1998-04-14
CZ299248B6 (cs) 2008-05-28
DE69708428T2 (de) 2002-07-04
DE69708428D1 (de) 2002-01-03
DK0831098T3 (da) 2002-05-21
NO991382L (no) 1999-03-22
ES2166051T3 (es) 2002-04-01
EP0831098A3 (en) 1998-04-29
AR013838A1 (es) 2001-01-31
UA59371C2 (uk) 2003-09-15
CA2265712A1 (en) 1998-03-26
EA001642B1 (ru) 2001-06-25
EG23861A (en) 2007-11-18
EP0831098B1 (en) 2001-11-21
HK1009807A1 (en) 1999-06-11
TR199900640T2 (xx) 1999-06-21
HUP0000066A2 (hu) 2000-06-28
JP2001500877A (ja) 2001-01-23
BR9712100A (pt) 1999-08-31
SI0831098T1 (en) 2002-04-30
CN1234802A (zh) 1999-11-10
HUP0000066A3 (en) 2000-11-28
PL196068B1 (pl) 2007-12-31
IN187156B (OSRAM) 2002-02-16
US6020487A (en) 2000-02-01
PT831098E (pt) 2002-04-29
ID27275A (id) 2001-03-22
AU719441B2 (en) 2000-05-11
EA199900326A1 (ru) 1999-08-26
TW470746B (en) 2002-01-01
NO991382D0 (no) 1999-03-22
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
HU226484B1 (en) 2009-03-02
KR20000048520A (ko) 2000-07-25
CN1122036C (zh) 2003-09-24
MY125565A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
CO4910140A1 (es) Intermediarios y proceso para preparar olanzapina
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
NO870492D0 (no) Fremgangsmaate for foring av roerledning.
DE69824481D1 (de) Verfahren zur Herstellung von FET-Bauelementen mit flacher,maskenloser Grabenisolation
AR002651A1 (es) Procedimiento integrado para la producción de 1-buteno
BR0008309B1 (pt) processo para criar uma superfÍcie de concreto com padrço.
ES525304A0 (es) Procedimiento para la produccion de velulosa
ES543147A0 (es) Procedimiento para la obtencion de 1,2-diacil-sn-glicero-3- fosfocolinas y 1,2-diacil-sn-glicero-3-fosfoetanolaminas sustituidas en forma mixta
EA200100208A1 (ru) Новая форма соли пантопразола
DE69838770D1 (de) Verfahren zur Herstellung elektrolumineszierender Vorrichtungen
ES2022133B3 (es) Procedimiento para el secado por congelacion de ciclofosfamida.
DE3852238D1 (de) Zur Herstellung von Keramik geeignete Polycarbosilanderivate.
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
DE50009949D1 (de) Verfahren zur Herstellung von natriumionenarmen Diazoniumverbindungen
NO986086D0 (no) FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11
PT1056362E (pt) Processo para a preparacao de cargas fragmentadas para cigarros
MX9102521A (es) Metodo para formar paquetes de tira metalica amorfa para fabricacion de nucleos de transformador.
EE9900373A (et) Protsess bensotiasoloonühendite valmistamiseks
DE60005586D1 (de) Verfahren zur Herstellung alkylsubstituierter Hydrochinone
DE69806357D1 (de) Verfahren zur Herstellung fotowirksamer Coumarinderivate
ES2020158A4 (es) Procedimiento para la produccion de monosulfuro sodico
ES2184151T3 (es) Procedimiento para preparar derivados de cianofosfonato a partir de anhidrido fosforico y cianuro.
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
DE69816074D1 (de) Verfahren zur Herstellung von Coumarinsulfonaten
ES524427A0 (es) Procedimiento para la obtencion de dihidrato de dicloroisocianurato sodico